Advantage Alpha Capital Partners LP Voyager Therapeutics, Inc. Transaction History

Advantage Alpha Capital Partners LP

  • $419 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$7.42 - $10.54 $86,294 - $122,580
-11,630 Reduced 9.51%
110,681 $875,000
Q1 2024

May 13, 2024
SELL
$7.15 - $10.84 $390,104 - $591,430
-54,560 Reduced 30.85%
122,311 $1.14 Million
Q4 2023

Feb 13, 2024
BUY
$6.28 - $8.81 $1.11 Million - $1.56 Million
176,871 New
176,871 $1.49 Million

Others Institutions Holding VYGR

# of Institutions
130
Shares Held
34.7M
Call Options Held
39.7K
Put Options Held
34.6K
View Full List

About Voyager Therapeutics, Inc.

VYGR Quotes by TradingView
  • Ticker VYGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,647,600
  • Market Cap $223M
  • Description
  • Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...
More about VYGR
Track This Portfolio

Track Advantage Alpha Capital Partners LP Portfolio

Follow Advantage Alpha Capital Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email